YY 0793.3-2023 in English
VALIDPreparation and quality control of fluids for hemodialysis and related treatments - Part 3: Concentrates for hemodialysis and related treatments
- Issued on:2023-06-20
- Implemented on:2025-07-01
- File Format:PDF
- Delivery:Via email within 1~3 business days
$243.00
本文件规定了血液透析和相关治疗用浓缩物的技术要求。
本文件适用于血液透析和相关治疗用浓缩物。
本文件不适用于在透析液使用机构利用预包装的盐和水配制成的浓缩物以及透析液的再生系统。
Introduction
Core changes in the standard update
| Technical indicators | YY 0598-2015 | YY 0793.3-2023 | Clinical significance |
|---|---|---|---|
| Microbial limits | Ungraded requirements | Aerobic bacteria ≤100CFU/mL Mold ≤10CFU/mL | Reduce the risk of infection |
| Endotoxin control | Detection method not specified | Endotoxin in dialysate <0.5EU/mL | Prevent pyrogenic reaction |
| Online B dry powder control | No special requirements | Added pH value and solute concentration detection | Ensure online preparation stability |
Analysis of key technical requirements
Solute concentration control
The standard stipulates that the allowable deviation of sodium ion concentration is 97.5%-102.5% of the labeled amount, and other ions are controlled in the range of 95%-105%. The detection method shall give priority to the method of "Chinese Pharmacopoeia", among which:
- Ion chromatography (arbitration method) is recommended for calcium/magnesium ions
- Bicarbonate containing sodium acetate shall adopt the back titration method in Appendix E
- Added liquid chromatography detection method for citrate
Implementation suggestions
Key points of quality control
- Chemical raw and auxiliary materials must comply with the pharmacopoeia standards in Appendix D, with special attention to the special grade requirements of calcium chloride·2H₂O and sodium bicarbonate
- Filters below 1μm shall be used for particle control, and the filter membrane material shall be recorded
- Online B dry powder shall be verified by time gradient sampling (at least 4 time points)
Analysis of differences in international standards
Compared with ISO 23500-4:2019, the main adjustments include: deleting the additive clause, strengthening the pharmacopoeia test method, and adding special requirements for online B dry powder. These modifications are more in line with China's actual clinical application scenarios, such as:
- Change the production water standard to reference YY 0572
- Clarify that dialysis concentrate does not include a regeneration system
- Add pH value as a mandatory test item

Loading PDF document...
Error loading PDF. Please make sure the file is valid and try again.
We also recommend
-

YY/T 0063-1991 in English
Medical diagnostic X-ray tube assembly focus characteristics
1991-11-21 -

YY 0989.3-2023 in English
Implants for surgery - Active implantable medical devices - Part 3: implantable neurostimulators
2023-06-20 -

YY 0059-1991 in English
dental handpiece
1991-11-21 -

YY/T 1927-2024 in English
Implants for sports medicine-Suture button
2024-02-07 -

YY/T 1156-2009 in English
Thrombin time reagent(Kit)
2009-12-30 -

YY/T 0085.1-1992 in English
Pulse vacuum pressure steam sterilizer
1992-01-21 -

YY/T 0085.2-1992 in English
Forevacuum pressure steam sterilizer
1992-01-21